EUVIMEDUpptäck EUVIMED
Crossref

Tyrosine kinase inhibitors in differentiated thyroid carcinoma: a review of the clinical evidence

Hendrieke C Hoftijzer, Ellen Kapiteijn, Tatiana Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit

Clinical Investigation · 2011

DOI: 10.4155/cli.10.29 ↗

At a glance

Journal article in Clinical Investigation, 2011. Written by Hendrieke C Hoftijzer and 6 co-authors. Cited 3 times so far (Crossref); 126 references.

AbstractBibliografiska uppgifterCiteRelated studies

Abstract (original language)

Inget abstract tillgängligt.

Cite

APA

Hoftijzer, H. C., Kapiteijn, E., Schneider, T., Hovens, G. C., Morreau, H., Gelderblom, H., & Smit, J. W. (2011). Tyrosine kinase inhibitors in differentiated thyroid carcinoma: a review of the clinical evidence. Clinical Investigation. https://doi.org/10.4155/cli.10.29

Vancouver

Hoftijzer HC, Kapiteijn E, Schneider T, Hovens GC, Morreau H, Gelderblom H, et al. Tyrosine kinase inhibitors in differentiated thyroid carcinoma: a review of the clinical evidence. Clinical Investigation. 2011. doi:10.4155/cli.10.29

BibTeX
@article{Hoftijzer2011,
  author = {Hoftijzer, Hendrieke C and Kapiteijn, Ellen and Schneider, Tatiana and Hovens, Guido C and Morreau, Hans and Gelderblom, Hans and Smit, Johannes WA},
  title = {Tyrosine kinase inhibitors in differentiated thyroid carcinoma: a review of the clinical evidence},
  journal = {Clinical Investigation},
  year = {2011},
  doi = {10.4155/cli.10.29}
}
Start for free →